Drug-Stocks im Aufwind
Seite 151 von 160 Neuester Beitrag: 03.03.24 15:26 | ||||
Eröffnet am: | 10.02.13 14:42 | von: SherlockHolm. | Anzahl Beiträge: | 4.987 |
Neuester Beitrag: | 03.03.24 15:26 | von: rolliv | Leser gesamt: | 343.511 |
Forum: | Hot-Stocks | Leser heute: | 18 | |
Bewertet mit: | ||||
Seite: < 1 | ... | 149 | 150 | | 152 | 153 | ... 160 > |
~WochenrückblickKW17
Ist die Zeit des Einstiegs gekommen?
Wochenrückblick CannaIndex
Chartgallerie kurzfristig
Aktien im Fokus: Kurskapriolen bei MASSROOTS (MSRT)
ANMATHE BETEILIGUNGS AG plant Umfirmierung zu Cannabis-BRANDS AG
GW PHARMACEUTICALS (GWPH) und Insys Therapeutics Inc. (INSY) mit neuen Hochs
Hallo allerseits, wie gewohnt der Wochenrückblick...
Ist die Zeit nun endlich reif in den Marihuana-Aktienmarkt einzusteigen?
Zweifelsohne hellt sich die Stimmung gegenüber der Legalisierung von Cannabis zusehens auf. Der jüngsten Umfrage von "General Social Survey" zu Folge stieg die Zahl der Cannabisbefürworter von 16% (1990) auf stolze 52% (2014) an.
Nachdem bereits 24 Bundesstaaten medizinisches Marihuana und Alaska, Colorado, Oregon, Washington und Washington D.C. Marihuana generell legalisiert haben, diskutieren zu dieser Stunde weitere US-Bundesstaaten über die Öffnung des Marktes und zeigen sich zusehens v.a. der medizinischen Verwendung aufgeschlossener. Fragt man die Amerikaner ausschließlich danach, ob sie einen rein medizinischen Gebrauch der Pflanze befürworten würden, schnellt der Prozentwert dramatisch in die Höhe. Eine aktuelle Studie der Quinnipac University zeigte, dass 84 % der Befragten in Florida und Ohio den medizinischen Gebrauch von Marihuana befürworten. In Pennsylvania stieg die Quote gar auf 88 %.
Agritek Holdings, Inc. Announces Appointment of Veteran Pharmaceutical Industry Executive Dr. Stephen Holt as Advisory Board Member
Download PDF
LOS ANGELES, CA -- (Marketwired) -- 04/27/15 -- Agritek Holdings, Inc. (OTCQB: AGTK) (http://www.Agritekholdings.com), a fully reporting company on the OTCQB and leader in Compassionate Care Technology and indoor/outdoor agricultural solutions for the medicinal cannabis industry, today announced the appointment of Dr. Stephen Holt, a nationally recognized licensed physician and author as the newest member of the Company's Advisory Board. In his capacity on the Advisory Board, Dr. Holt will utilize his extensive clinical and industry experience to assist Agritek in effectively developing intellectual property within the nutraceutical sector, while at the same time establishing new CBD based product lines.
Currently, Dr. Stephen Holt, M.D., is a Distinguished Professor of Medicine NYCPM (Emeritus) and a medical practitioner in New York State. He has published many peer-review papers in medicine and he is a best-selling author with more than twenty books in national and international distribution. His newly published book "The Cannabis Revolution" is expected to be released in the next few months. He has received numerous awards for teaching and research within the nutritional sector. Dr. Holt is a frequent lecturer at scientific meetings and healthcare facilities throughout the world and the founder of the Holt Institute of Medicine.
ABBREVIATED CURRICULUM VITAE
STEPHEN HOLT, MD, LLD(Hon.), PhD, DSc, ChB., DNM, DACBN, FRCP (C)
MRCP (UK), FACP, FACG, FACN, FACAM, OSJ
CURRENT APPOINTMENTS:
Consultant Physician in Gastroenterology, Medicine and Nutrition, New York
Board member, Integrative Medicine Asia
Board member, Global Foundation of Integrative Medicine
Board member, European Society of Anti-Aging Medicine
Liaison, American Clinical Board of Nutrition
EDUCATION:
Honors Graduate 1972, Liverpool University Medical school, England, UK
Postgraduate Training Internal Medicine and Gastroenterology, Therapeutics/Clinical Pharmacology and Nutrition
Board Certified Internist and Sub specialist in USA, UK, Economic Union and Canada
HONORS:
Honorary Doctorate of Humane Letters, LLD (LHD), New York, USA
Congressional Medal of Distinction 2006, National Republican Congressional Committee
Several Awards for Teaching
RESEARCH:
Nutrition, Gastrointestinal Disease and Therapeutics.
PUBLICATIONS
Author or co-author -- more than 30 books and several hundred scientific communications, with thousands of publications or citations in medical consumer or trade press.
STEPHEN HOLT, MD: SUMMARY OF PROFESSIONAL ACTIVITIES
Business founder and owner: Natural Clinician LLC, www.naturalclinician.com, Global Health Care LLC, www.ghcdirect.com, and Holt Institute of Medicine, www.hiom.org.
Biographical Sketch at www.stephenholtmd.com.
Owner/Operator Cartilage Technologies Inc. (Biotherapies Inc. 1992 - 2000.) Bulk producer, Manufacturer, Sales and Marketing of marine nutraceuticals.
Academic rank: Distinguished Professor of Medicine (Emerite).
Educator: Academic staff, sales staff, marketing professionals in the nutritional industry.
Nutritional Expert in all media formats.
Best selling author.
Board certified in internal medicine, gastroenterology and nutrition.
Justin Braune, CEO for Agritek Holdings, stated, "The addition of Dr. Stephen Holt to our advisory team brings tremendous credibility to our Company. We expect that upon the release of his newly authored book 'The Cannabis Revolution' and his many years of experience within the pharmaceutical manufacturing sector, our newly established models of licensing CBD based tinctures and products will have meaningful impact through his guidance, endorsement and already established professional distribution channels.
Dr. Holt, upon his appointment to Agritek, stated, "I believe the Agritek model of owning the agricultural real estate and working with established licensees in legal jurisdictions will allow me to use my professional expertise within the nutritional and nutraceutical marketplace and allow us to create a line of CBD based products that can genuinely make a difference in people's lives, health and well-being. I look forward to providing my knowledge, contacts within the medical community and expertise allowing Agritek the opportunity to increase revenues through products I have already created and have in distribution pipelines as we penetrate this rapidly emerging market."
About Agritek Holdings, Inc.
Agritek Holdings, Inc. (www.Agritekholdings.com), a fully reporting Company and pioneer within the medicinal marijuana space, provides innovative patient and agricultural solutions and seeks to be the leader in Compassionate Care Technology for the medicinal marijuana industry. Agritek Holdings provides real estate management and health and wellness product lines including through its wholly owned subsidiary Agritek Venture Holdings Inc. Agritek does not directly grow, harvest, or distribute or sell cannabis or any substances that violate or contravene United States law or the Controlled Substances Act, nor does it intend to do so in the future.
FORWARD-LOOKING DISCLAIMER:
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Agritek Holdings, Inc. to be materially different from the statements made herein.
Contact:
Agritek Holdings, Inc.
561.249.6511
www.Agritekholdings.com
info@Agritekholdings.com
Source: Agritek Holdings, Inc.
Released April 27, 2015
LinK: http://ir.agritekholdings.com/press-releases/detail/1175
WochenrückblickKW20
-Wochenrückblick CannaIndex
-Chartgallerie
-Earning-Season: Ergebnisse über Ergebnisse: INSY, GWPH, FULL, XXII & CARA
-Unternehmensnachrichten
-Marihuana-Legalisierungsdebatte in Deutschland
-AVT Insolvenz ?
CannaIndex
Der CannaIndex geht in KW 20 nahezu unverändert aus der Woche und schließt mit einem Minus von -1,11%.
Mehr Infos: http://www.marihuana-aktien.de/news/wochenruckblick-kw-20/
Ich würde eventuell mit einer kleinen posi. nachkaufen wenn ich schon nicht bei 0,018 cent nachgekauft hätte.
Ich sehe in Cannabis enormes Potential.
Aber zur Zeit ist echt schwierig zu sagen welche Cannabis-Aktie man kaufen soll/kann.
Die anderen Gras-Aktien in der Watchlist sind auch nur noch am fallen.
Gibt es zur Zeit überhaupt eine Gras-Aktie die zur Zeit steigt? Welche könnt ihr noch empfehlen ?
WochenrückblickKW25
- Neues auf marihuana-aktien.de
- Wochenrückblick CannaIndex
- Chartgallerie
- Unternehmensnachrichten
- Blogbeiträge zu Totally Hemp Crazy, GW Pharmaceuticals und INSYS Therapeutics
- Deutsche Cannabis AG nach der Schockmeldung
Mehr Infos: http://www.marihuana-aktien.de/blog-2/
vielleicht zieht sie auch wieder hoch. Potential ist vorhanden.
Hab mir schon kleine Position aufgebaut.